- Home
- EDUC vs ERNA Comparison
EDUC vs ERNA Comparison
Compare EDUC & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDUC
- ERNA
- Stock Information
- Founded
- EDUC 1965
- ERNA 2018
- Country
- EDUC United States
- ERNA United States
- Employees
- EDUC N/A
- ERNA N/A
- Industry
- EDUC Consumer Specialties
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- EDUC Consumer Discretionary
- ERNA Health Care
- Exchange
- EDUC Nasdaq
- ERNA Nasdaq
- Market Cap
- EDUC 11.7M
- ERNA 10.2M
- IPO Year
- EDUC N/A
- ERNA N/A
- Fundamental
- Price
- EDUC $1.51
- ERNA $1.22
- Analyst Decision
- EDUC
- ERNA
- Analyst Count
- EDUC 0
- ERNA 0
- Target Price
- EDUC N/A
- ERNA N/A
- AVG Volume (30 Days)
- EDUC 62.0K
- ERNA 78.6K
- Earning Date
- EDUC 10-09-2025
- ERNA 11-11-2025
- Dividend Yield
- EDUC N/A
- ERNA N/A
- EPS Growth
- EDUC N/A
- ERNA N/A
- EPS
- EDUC N/A
- ERNA N/A
- Revenue
- EDUC $29,415,900.00
- ERNA $488,000.00
- Revenue This Year
- EDUC N/A
- ERNA N/A
- Revenue Next Year
- EDUC N/A
- ERNA N/A
- P/E Ratio
- EDUC N/A
- ERNA N/A
- Revenue Growth
- EDUC N/A
- ERNA 201.24
- 52 Week Low
- EDUC $0.92
- ERNA $1.09
- 52 Week High
- EDUC $2.15
- ERNA $18.75
- Technical
- Relative Strength Index (RSI)
- EDUC 56.87
- ERNA 45.12
- Support Level
- EDUC $1.38
- ERNA $1.25
- Resistance Level
- EDUC $1.51
- ERNA $1.34
- Average True Range (ATR)
- EDUC 0.11
- ERNA 0.08
- MACD
- EDUC -0.00
- ERNA 0.01
- Stochastic Oscillator
- EDUC 60.10
- ERNA 43.33
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.